| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 02/03/2005 | WO2005009348A2 Substituted purine derivatives |
| 02/03/2005 | WO2005009343A2 A1 adenosine receptor antogonists |
| 02/03/2005 | WO2005009334A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 02/03/2005 | US20050026939 Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction |
| 02/03/2005 | US20050026938 Purine inhibitors of protein kinases, G proteins and polymerases |
| 02/03/2005 | US20050026174 Alternative heterocycles for DNA recognition |
| 02/03/2005 | DE10130504B4 Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung Xanthine-phenazone and acesulfame-H-complexes with improved taste, process for their preparation and their use |
| 02/03/2005 | CA2522338A1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 02/02/2005 | EP1502914A1 Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives |
| 02/02/2005 | EP1501812A1 Pna monomer and precursor |
| 02/02/2005 | EP0912575B1 Processes for the synthesis of chemical compounds having pde-iv inhibitory activity |
| 02/02/2005 | CN1187354C Adenosine receptor antagonists and methods of making and using the same |
| 02/02/2005 | CN1187051C Xanthine-based compound for preparation of medicine for enhancing insulin action |
| 02/01/2005 | US6849737 Synthesis and purification of valacyclovir |
| 02/01/2005 | US6849736 Crystalline forms of valacyclovir hydrochloride |
| 02/01/2005 | US6849735 Making N-4-carboxyphenyl-3-(6-oxohydropurin-9-yl) propanamide starting from aminopropionic acid, ethyl p-aminobenzoate, and using aminocyanoacetamide |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849623 For use as human and veterinary medicine |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 02/01/2005 | CA2320448C 6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino]purines |
| 01/27/2005 | WO2005007658A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007167A1 Solid pharmaceutical preparation |
| 01/27/2005 | US20050020532 Partial and full agonists of A1 adenosine receptors |
| 01/27/2005 | CA2532093A1 Solid formulation |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1499713A2 Genomic library of cyanophage s-2l and functional analysis |
| 01/26/2005 | EP1499613A1 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/25/2005 | US6846927 Multistep synthesis of penciclovir or famciclovir starting with 2-amino-6-chloropurine |
| 01/20/2005 | US20050014943 Reacting 5-aminoimidazole-4-carboxamide with triethyl orthoformate; cyclization; hydrolysis |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/19/2005 | EP1496896A1 Inhibitors of akt activity |
| 01/19/2005 | EP1124562B1 Combination therapy to treat hepatitis b virus |
| 01/19/2005 | CN1566118A Antiviral activity possessed compound and preparation method thereof |
| 01/13/2005 | WO2005003100A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 01/13/2005 | WO2004078943A3 Alternative heterocycles for dna recognition |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050009846 2,6,9-Substituted purine derivatives and their use in the treatment of proliferative disorders |
| 01/13/2005 | US20050009842 2-hydroxymethylcyclopropylidene methylpurines and -pyrimidines as antiviral agents |
| 01/13/2005 | US20050009829 1-Substituted 2-carboxamide derivatives of fused ring imidazoles, e.g., -[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-benzoimidazole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide |
| 01/13/2005 | US20050009076 Conjugate of hormone (thyroxine) and inosine-5'-monophosphate dehydrogenase inhibitor (such as mycophenolic acid) |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/12/2005 | CN1564688A Methods of treating pulmonary disease |
| 01/12/2005 | CN1563007A 9-(2-fatty ester ethoxy methyl) guanine, liposome, and preparation emthod |
| 01/12/2005 | CN1563006A Synthesizing nucleoside analog for antivirus |
| 01/11/2005 | US6841549 Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| 01/06/2005 | WO2005000850A2 Novel crystalline forms of valacyclovir hydrochloride |
| 01/06/2005 | WO2005000404A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 01/06/2005 | WO2005000313A1 Antiepileptic agent |
| 01/06/2005 | WO2004073595A3 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 01/06/2005 | US20050004207 Substituted isoindoles and the use thereof |
| 01/06/2005 | US20050004117 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | CA2530649A1 Antiepileptic agent |
| 01/06/2005 | CA2527708A1 Crystalline forms of valacyclovir hydrochloride |
| 01/06/2005 | CA2527079A1 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1492803A1 New analogs of nitrobenzylthioinosine |
| 01/05/2005 | EP1492791A1 Crystal and solvate of 2-amino-6-benzyloxypurine and production methods thereof |
| 01/05/2005 | CN1183133C 2-amino-6-anilino-purines and their use as medicaments |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 12/30/2004 | US20040267034 Hydrogenation process |
| 12/30/2004 | US20040266795 reacting a compound of formula I (acetic acid 2-acetoxymethyl-4-(5-amino-7-chloro-imidazo[4,5-b]pyridin-3-yl)-butyl ester) in the presence of a catalyst in a C1-C6 alkyl acetate and ammonium formate |
| 12/30/2004 | US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 12/29/2004 | WO2004113357A2 Nucleoside analog inhibitors of reverse transcriptase |
| 12/29/2004 | WO2004009091A8 Purine derivatives as liver x receptor agonists |
| 12/29/2004 | EP1490369A1 Production method of 2,6-dihalopurine |
| 12/29/2004 | EP1490368A2 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents |
| 12/29/2004 | EP1490367A1 Imidazopyridine derivatives as kinase inhibitors |
| 12/29/2004 | EP1490366A1 Novel alkoxypyridine-derivatives |
| 12/29/2004 | EP1490015A2 Novel 2-amino-9-((2-hydroxymethyl) cyclopropylidenemethyl) purines as antiviral agents |
| 12/29/2004 | CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer |
| 12/29/2004 | CN1557841A Process for synthetic extraction of polysaccharides, tea-polyphenol, theanine, caffeine from tea |
| 12/29/2004 | CN1182137C Preparation method and use of sodium Penciclovir sodium hydrate |
| 12/23/2004 | WO2004111049A1 Ganciclovir sodium salt in crystalline form |
| 12/23/2004 | WO2004111007A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
| 12/23/2004 | WO2004110379A2 A1 adenosine receptor antagonists |
| 12/23/2004 | WO2004110343A2 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same |
| 12/23/2004 | WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 12/23/2004 | WO2004040003A3 Nucleotide-binding protein-directed probes and methods of their synthesis and use |
| 12/23/2004 | US20040259889 Vasconstriction ; administering adenosine receptor antagonist |
| 12/23/2004 | US20040259870 Antidiabetic agents; obesity; controlling appetite |
| 12/23/2004 | US20040259833 DNA methyl transferase inhibitors |
| 12/23/2004 | US20040259832 Synergistic mixture of thymidine kinase inhibitor and viricides |
| 12/23/2004 | CA2798163A1 Inosine derivatives and production methods therefor |
| 12/23/2004 | CA2727748A1 Inosine derivatives and production methods therefor |
| 12/23/2004 | CA2528367A1 A1 adenosine receptor antagonists |
| 12/23/2004 | CA2526518A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
| 12/22/2004 | CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme |
| 12/21/2004 | US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders. |
| 12/21/2004 | US6833375 As inhibitors of the retinoic acid-metabolism, as drugs |
| 12/16/2004 | WO2004035740A3 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 12/16/2004 | US20040254201 Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
| 12/16/2004 | US20040254141 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents |
| 12/16/2004 | US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist |
| 12/15/2004 | EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same |
| 12/15/2004 | EP0788507B1 L-pyranosyl nucleosides |
| 12/15/2004 | CN1554350A Nucleotide analog composition and synthesis method |
| 12/14/2004 | US6831174 Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties |